Is transition zone biopsy valuable in benign prostatic hyperplasia patients with serum prostate-specific antigen >10 ng/ml and prior negative peripheral zone biopsy?

By Abdel-Khalek Mohamed   Sheir Khaled   El-Baz Mahmoud   Ibrahiem El-Houssieny  

Scandinavian Journal of Urology and Nephrology, Vol. 39, Iss. 1, 2005-02 ,pp. : 49-55

Informa Healthcare

Access to resources Recommend Favorite

''BPSA,'' a specific molecular form of free prostate-specific antigen, is found predominantly in the transition zone of patients with nodular benign prostatic hyperplasia1

By Mikolajczyk S.D.   Millar L.S.   Wang T.J.   Rittenhouse H.G.   Wolfert R.L.   Marks L.S.   Song W.   Wheeler T.M.   Slawin K.M.  

Urology, Vol. 55, Iss. 1, 2000-01 ,pp. : 41-45

Elsevier

Access to resources Recommend Favorite

Is the Higher Prevalence of Benign Prostatic Hyperplasia Related to Lower Urinary Tract Symptoms in Korean Men due to a High Transition Zone Index?

By Choi J.   Ikeguchi E.F.   Lee S.W.   Choi H.Y.   Te A.E.   Kaplan S.A.  

European Urology, Vol. 42, Iss. 1, 2002-07 ,pp. : 7-11

Elsevier

Access to resources Recommend Favorite

Limitations of transition zone needle biopsy findings in the prediction of transition zone cancer and tissue composition of benign nodular hyperplasia

By McNeal J.   Noldus J.  

Urology, Vol. 48, Iss. 5, 1996-11 ,pp. : 751-756

Elsevier

Access to resources Recommend Favorite

Long-term 6-year experience with finasteride in patients with benign prostatic hyperplasia

By Lowe F.C.   McConnell J.D.   Hudson P.B.   Romas N.A.   Boake R.   Lieber M.   Elhilali M.   Geller J.   Imperto-McGinely J.   Andriole G.L.   Bruskewitz R.C.   Walsh P.C.   Bartsch G.   Nacey J.N.   Shah S.   Pappas F.   Ko A.   Cook T.   Stoner E.   Waldstreicher J.   FINASTERIDE STUDY GROUP  

Urology, Vol. 61, Iss. 4, 2003-04 ,pp. : 791-796

Elsevier

Access to resources Recommend Favorite